AKT3 and hepatocellular carcinoma: Via directly suppressing CDK1 and v-akt murine thymoma viral oncogene homolog 3 (AKT3) expression and indirectly inhibiting cyclinD1 expression; miR-582-5p functions in the development and progression of HCC [34].